78.75
3.85%
2.92
アフターアワーズ:
79.00
0.25
+0.32%
前日終値:
$75.83
開ける:
$76.49
24時間の取引高:
865.73K
Relative Volume:
1.00
時価総額:
$12.51B
収益:
$1.17B
当期純損益:
$150.71M
株価収益率:
83.78
EPS:
0.94
ネットキャッシュフロー:
$245.03M
1週間 パフォーマンス:
+5.38%
1か月 パフォーマンス:
+7.63%
6か月 パフォーマンス:
+4.36%
1年 パフォーマンス:
+11.99%
Bio Techne Corp Stock (TECH) Company Profile
TECH を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
78.75 | 12.51B | 1.17B | 150.71M | 245.03M | 0.94 |
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-05-22 | ダウングレード | Citigroup | Buy → Neutral |
2024-02-08 | 開始されました | Scotiabank | Sector Outperform |
2024-02-02 | ダウングレード | Stifel | Buy → Hold |
2023-12-07 | 開始されました | UBS | Buy |
2023-08-28 | 開始されました | William Blair | Outperform |
2023-01-10 | アップグレード | Wells Fargo | Underweight → Equal Weight |
2022-12-14 | 開始されました | Deutsche Bank | Buy |
2022-12-12 | アップグレード | Citigroup | Neutral → Buy |
2022-12-07 | 開始されました | RBC Capital Mkts | Sector Perform |
2022-08-25 | 開始されました | Credit Suisse | Outperform |
2022-04-25 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
2021-09-15 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
2021-03-08 | アップグレード | Stephens | Equal-Weight → Overweight |
2021-02-23 | アップグレード | Stifel | Hold → Buy |
2021-01-25 | 繰り返されました | The Benchmark Company | Buy |
2020-11-10 | 開始されました | KeyBanc Capital Markets | Sector Weight |
2020-09-30 | 開始されました | Atlantic Equities | Overweight |
2020-07-15 | ダウングレード | Stephens | Overweight → Equal-Weight |
2020-05-27 | ダウングレード | Stifel | Buy → Hold |
2020-05-14 | 開始されました | The Benchmark Company | Buy |
2020-01-08 | 再開されました | Stephens | Overweight |
2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
2020-01-07 | 開始されました | Citigroup | Neutral |
2019-11-15 | 開始されました | Stifel | Buy |
2019-07-02 | アップグレード | Janney | Neutral → Buy |
2019-01-14 | アップグレード | Stephens | Equal-Weight → Overweight |
2018-10-31 | ダウングレード | Craig Hallum | Buy → Hold |
2018-10-17 | 開始されました | Goldman | Neutral |
2018-06-15 | 開始されました | Argus | Buy |
2017-07-13 | 開始されました | Wells Fargo | Market Perform |
2017-02-09 | 開始されました | Citigroup | Buy |
2017-01-18 | 開始されました | Deutsche Bank | Buy |
2016-11-10 | 再開されました | Leerink Partners | Outperform |
2015-01-21 | 繰り返されました | Robert W. Baird | Outperform |
2013-09-20 | アップグレード | Robert W. Baird | Neutral → Outperform |
すべてを表示
Bio Techne Corp (TECH) 最新ニュース
ScaleReady Announces a G-Rex® Grant has been awarded to BrainChild Bio - Yahoo Finance
Bio-Techne Earnings Preview: What To Expect - Barchart
Bio-Techne Co. (NASDAQ:TECH) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch
Is There Now An Opportunity In Bio-Techne Corporation (NASDAQ:TECH)? - Yahoo Canada Finance
TECH Stock Might Rise From the Expansion of Designer Protein Portfolio - Yahoo Finance
Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine - WV News
Single-use Bioprocessing Probes and Sensors Market Forecast to Reach $10.95 Billion by 2034 - GlobeNewswire Inc.
ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics - Yahoo Finance
GAMMA Investing LLC Buys 333 Shares of Bio-Techne Co. (NASDAQ:TECH) - Defense World
Bio-Techne Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Bio-Techne wins patent case against Miltenyi Biotec - Investing.com
BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC - Yahoo Finance
3 Genomic Stocks Unlocking the Secrets of DNA - Inkl
BNTX: 3 Genomic Stocks Unlocking the Secrets of DNA - StockNews.com
JPMorgan Chase & Co. Sells 280,782 Shares of Bio-Techne Co. (NASDAQ:TECH) - Defense World
Bio-Techne Corp. stock outperforms competitors despite losses on the day - MarketWatch
Short Interest in Bio-Techne Co. (NASDAQ:TECH) Drops By 14.0% - MarketBeat
Bio-Techne Co. (NASDAQ:TECH) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Bio-Techne Corp. stock rises Tuesday, still underperforms market - MarketWatch
How Is Bio-Techne’s Stock Performance Compared to Other Biotechnology Stocks? - Nasdaq
How Is Bio-Techne’s Stock Performance Compared To Other Biotechnology Stocks? - Barchart
Bio-Techne Inks New Agreement With Waters Corporation: Stock to Gain? - Yahoo Finance
BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE - Financial Times
Bio-Techne Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Bio-Techne partners with Waters for biotherapeutic tech - Investing.com
BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT - Quantisnow
ScaleReady awards a G-Rex® Grant to Moonlight Bio - Quantisnow
Lord Abbett & CO. LLC Has $23.73 Million Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Bio-Techne Co. (NASDAQ:TECH) Short Interest Up 15.6% in November - MarketBeat
Bio-Techne Co. (NASDAQ:TECH) Shares Sold by Toronto Dominion Bank - MarketBeat
Oddo BHF Asset Management Sas Invests $1.19 Million in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Barclays PLC Reduces Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Bio-Techne Launches ESR1 Mutation Monitoring Assay: Stock to Gain? - MSN
National Bank of Canada FI Purchases 37,181 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY - Quantisnow
S&P 500 Futures Rise in Premarket Trading; Bausch + Lomb, Bio-Techne Lag - Barron's
West Sac-based GeminiBio acquires a large serum producer's brands, customers - The Business Journals
BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY - Yahoo Finance
Wellington Management Group LLP Sells 147,797 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
State Street Corp Grows Stock Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Tenere Capital LLC Grows Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Worldquant Millennium Advisors LLC Buys 22,185 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Polar Asset Management Partners Inc. Lowers Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Janus Henderson Group PLC Lowers Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Can Mixed Financials Have A Negative Impact on Bio-Techne Corporation's 's (NASDAQ:TECH) Current Price Momentum? - Yahoo Finance
PEAK6 Investments LLC Invests $698,000 in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Exosome Research Products Industry Research Report 2023-2030, Featuring AMS, Bio-Techne, Lonza, Miltenyi Biotech, Nanosomix, Norgen Biotek, NX Pharmagen, Qiagen, SBI, Thermo Fisher Scientific - Yahoo Finance
Bio Techne Corp (TECH) 財務データ
収益
当期純利益
現金流量
EPS
Bio Techne Corp (TECH) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Hippel James | CFO |
Nov 01 '24 |
Option Exercise |
0.00 |
13,159 |
0 |
113,085 |
HIGGINS JOHN L | Director |
Sep 12 '24 |
Option Exercise |
22.95 |
6,000 |
137,700 |
48,608 |
Kelderman Kim | Chief Executive Officer |
Aug 29 '24 |
Option Exercise |
66.97 |
1,492 |
99,919 |
41,434 |
Bohnen Shane | SVP - General Counsel |
Aug 15 '24 |
Option Exercise |
0.00 |
49 |
0 |
1,696 |
BAUMGARTNER ROBERT V | Director |
Aug 08 '24 |
Option Exercise |
22.95 |
16,000 |
367,200 |
59,401 |
BAUMGARTNER ROBERT V | Director |
Aug 08 '24 |
Sale |
72.10 |
16,000 |
1,153,664 |
43,401 |
大文字化:
|
ボリューム (24 時間):